Exploring new opportunities within the fast-growing market of microfluidics BORDEAUX,France,Feb. 20,2025-- Syensqo,a leading specialty chemicals company,is pleased to announce a strategic partnership

BEIJING,Feb. 20,2025-- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"),the leading online destination for automobile consumers in China,today announced that th

STEINHAGEN,Germany,Feb. 20,2025-- Plasmatreat,a leading company in the field of surface treatment with plasma technology,developed the REDOX-Tool: an environmentally friendly,chemical-free solution f

HONG KONG,Feb. 21,2025-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) today announces that Luda 5-2 North Oilfield Phase II Development Projec

Key Proposals: Appointment of a Temporary Chair Full Cancellation of Treasury Shares Cash Dividend of KRW 7,500 per Common Share & Reclassification of Discretionary Reserves

YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1